Kate Therapeutics and Capsida Biotherapeutics collaborate on gene therapies
The companies aim to bring gene therapies to patients sooner than traditional approaches
Read More
Tag: gene therapies
Multi-million-pound funding for genomics research
Vital financing will help boost diagnosis, treatment and prospects of patient groups
Read More
CGT Catapult unveils major UK investment in skills and capabilities
The Cell and Gene Therapy Catapult (CGT Catapult) has announced a major investment in skills and capability training to help accelerate integration of cell and gene therapies into health services following their regulatory approval.
Read More
GSK hands rare disease gene therapies over to Orchard
Orchard Therapeutics has snapped up GlaxoSmithKline’s portfolio of approved and investigational rare disease gene therapies.
Read More
Charity slams government’s lack of response to access issues
Muscular Dystrophy UK is campaigning for faster approval and funding for therapies for children and adults with muscle-wasting treatments, and warns that the wait for a government response to the Accelerated Access Review “adds to delays to new drugs”.
Read More
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
